Inhibition of SH2-domain containing inositol phosphatase 2 (SHIP2) in insulin producing INS1E cells improves insulin signal transduction and induces proliferation |
| |
Authors: | Grempler Rolf Leicht Stefanie Kischel Ivonne Eickelmann Peter Redemann Norbert |
| |
Affiliation: | Department of Metabolic Diseases Research, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Strasse 65, D-88397 Biberach an der Riss, Germany. rolfgrempler@yahoo.de |
| |
Abstract: | Inhibition of the lipid phosphatase SH2-domain containing inositol phosphatase 2 (SHIP2) in L6-C10 muscle cells, in 3T3-L1 adipocytes and in the liver of db/db mice has been shown to ameliorate insulin signal transduction and established SHIP2 as a negative regulator of insulin action. Here we show that SHIP2 inhibition in INS1E insulinoma cells increased Akt, glycogen synthase kinase 3 and extracellular signal-regulated kinases 1 and 2 phosphorylation. SHIP2 inhibition did not prevent palmitate-induced apoptosis, but increased cell proliferation. Our data raise the interesting possibility that SHIP2 inhibition exerts proliferative effects in beta-cells and further support the attractiveness of a specific inhibition of SHIP2 for the treatment of type 2 diabetes. |
| |
Keywords: | βGal, beta-galactosidase ERK1/2, extracellular signal-regulated kinases 1 and 2 GLP-1, glucagon-like peptide 1 GSK3, glycogen synthase kinase 3 PI3K, phosphatidylinositol 3-kinase PKB (Akt), protein kinase B PtdIns(3,4,5)P3, phosphatidylinositol 3,4,5-trisphosphate SHIP2, SH2-domain containing inositol phosphatase 2 |
本文献已被 ScienceDirect PubMed 等数据库收录! |
|